INTRODUCTION
The obligate intracellular bacterium Chlamydia trachomatis is an important human pathogen responsible for blinding ocular disease (trachoma) in developing countries and for sexually transmitted diseases throughout the world. The disease process associated with chlamydial infections is thought to be principally immunologically mediated. Repeated episodes of infection clearly play a role in stimulating the host immune response and enhancing damaging pathologic changes. It is unclear, however, if reinfection alone or the presence of an altered form of chlamydiae, capable of persisting in an inapparent state, also contributes to the resulting pathologic changes. Persistent in cell culture and the corresponding features of these infections will be evaluated and correlated to hallmarks of natural chlamydial disease.
DEVELOPMENTAL CYCLE OF CHLAMYDIAE
Chlamydiae have successfully developed an obligate intracellular lifestyle, overcoming obstacles of entry into a host cell, subsistence and propagation inside the host cell, and survival during transit in a hostile extracellular environment. To overcome these obstacles, chlamydiae have evolved a developmental cycle encompassing alternating functional and morphological forms (122) . The elementary body (EB) is the infectious form of the organism, responsible for attaching to the target host cell and promoting its entry. The small, dense EB has a rigid cell wall conferred by extensive disulfide cross-linking of the major outer membrane protein (MOMP) and two cysteinerich proteins: the 60-kDa envelope protein and the 12-kDa outer membrane lipoprotein (28, 29, 42) . Interestingly, chlamydiae are among the few prokaryotes that do not have a cell wall composed of peptidoglycan (6, 31) , although cross-linking components analogous to pentapeptide structures may be present since chlamydial growth and division are altered in the presence of f-lactam antibiotics (59, 67) . The structural integrity of EBs confers resistance to environmental factors, thus permitting survival after lysis of the host cell and during subsequent transit from cell to cell as well as from host to host. In contrast, the reticulate body (RB) is the larger, metabolically active form of the organism, synthesizing DNA, RNA, and proteins. RBs are less-rigid, highly labile forms that do not survive outside the host cell (114) . EBs adaptations to extracellular and intracellular environments, respectively.
The chlamydial growth cycle is initiated when an infectious EB attaches to a susceptible host cell, promoting entry into a host cell-derived phagocytic vesicle (Fig. 1) . The (43) . Covalent cross-linking of these outer membrane proteins contributes to the structural integrity of the rigid EB (9, 42). Reduction of disulfide bonds results in increased membrane fluidity and porin activity, allowing for enhanced permeability, nutrient transport, and metabolic activity (9) . The absence of extensive cross-linking also accounts for the osmotically and mechanically fragile nature of RBs (34) . Although disulfidemediated interactions of chlamydial OMPs coincide with the conversion ofEBs to RBs, this event alone does not trigger differentiation. When chlamydial EBs are exposed to reducing conditions, a number of changes occur that are associated with differentiation to RBs (34) . Treatment of EBs with dithiothreitol results in a reduction in disulfide linkages with subsequent increased permeability and metabolic activity, decreased osmolarity and infectivity, and differential staining characteristics of RBs (34) . However, the chlamydiae retain discrete, compact, electron-dense nucleoid structures characteristic of EBs, suggesting that membrane structural reorganization alone is not sufficient to induce differentiation. In RBs the DNA is loosely packed, with diffuse fimbrils extending throughout the cytosol. Changes in the structural organization of the nucleoid appear to be imperative to the developmental progression of chlamydial growth. The decondensation of the chlamydial chromosome may be essential for transcriptional and translational activation. As the infectious process progresses, differentiation of RBs to infectious EBs is accompanied by reincorporation of MOMP and other OMPs into outer membrane complexes (43) . These events occur concomitant with the dramatic recondensation of the chlamydial chromosome.
The actual mechanisms that control and regulate intracellular development are unknown. Identification of temporally regulated proteins implicates an orderly system of developmental regulation in chlamydiae. Several stage-specific proteins are synthesized as early as 15 min postinfection (89) .
Synthesis of a number of proteins is associated transiently with primary differentiation, while other proteins continue to be produced at low levels throughout the late log phase of development (61, 89, 124) . Early-stage proteins identified include a homolog of bacterial glutamyl-tRNA synthetase (124) , the chlamydial Si ribosomal protein, a GroEL-like protein, and a DnaK-like protein (61) . The GroEL and DnaK proteins are both stress response proteins. Although their exact functions are not known, these proteins have been implicated in folding, unfolding, and translocation of proteins, as well as in assembly and disassembly of oligomeric complexes (27) . Early synthesis of these proteins precedes that of MOMP, a protein constitutively expressed throughout the intracellular growth of chlamydiae (112) . Synthesis of these stress proteins may play a role in the early survival and differentiation of EBs. Several late-stage-specific genes are expressed during the transition of RBs to EBs. These include those that encode envelope proteins (28, 34, 42, 43, 79) and DNA-binding proteins (7, 33, 85) . Synthesis of the cysteine-rich structural proteins commences when RBs initiate reorganization to EBs (42, 79) . Synthesis of a developmentally regulated protein with homology to eukaryotic histone Hi proteins was identified late in the developmental cycle and coincides with active chlamydial DNA synthesis and compaction of the chlamydial genome (7, 33, 85 (10, 66, 107) and deviations in the levels of essential nutrients (1, 25 (1) . This effect is reversible, with resumed differentiation to infectious forms, upon the addition of cysteine. The effect appears to be specific for cysteine, since the omission of other amino acids has little or no effect on chlamydial development. These observations suggest that an alteration in growth and differentiation arises via the requirement for this amino acid for the biosynthesis of three cysteinerich proteins needed for RB-to-EB differentiation.
More recently, intracellular development of C. trachomatis serovars E and L2 and three strains of C. psittaci in medium lacking all 13 amino acids was analyzed (25). Reduction in the amino acid concentrations results in reduced infectious yield, with the development of enlarged abnormal chlamydial forms. This effect is reversible, with a substantial recovery of infectivity upon the reintroduction of amino acids. In contrast to earlier studies, omission of any 1 of the 13 amino acids, with the exception of valine, from the growth medium induced aberrant chlamydial development.
The above studies suggest that factors that compromise the biosynthetic capacity of the host cell potentially have an amplified effect on intracellular chlamydiae. Under conditions in which the host's soluble pools for metabolic needs become limited, chlamydiae may fail to successfully compete for macromolecular precursors and hence may enter a state of arrested growth. Alterations in the extracellular environment that stimulate host cell proliferation may raise intracellular pools, reactivating persistent chlamydiae to a state of productive developmental growth.
Antimicrobial Agents and Persistence
A number of studies have analyzed antimicrobial agents as mediators of persistent chlamydial development. Treatment with penicillin has no effect on initial differentiation of the infecting EB to the RB but prevents the process of binary fission, inducing the development of enlarged, morphologically abnormal chlamydial forms with a block in the production of progeny EBs (67) . These aberrant forms have been found in both C. psittaci-and C. trachomatis-infected cultures treated with penicillin (3, 21, 24, 49, 59, 67) . Ultrastructural analysis reveals that the RB forms become progressively larger with continued culture in the presence of the antibiotic, with masses of membranes forming outside and inside the swollen RBs (67) . Removal of penicillin from the extracellular culture medium results in extensive budding and internal subdivision of the aberrant chlamydial forms, producing typical RBs (67) with maturation to infectious EBs (30) .
Unequal cellular division, with the formation of small daughter RBs, termed "miniature" RBs, budding both within and from enlarged chlamydial forms, is another feature observed with penicillin treatment (115) . In vivo features similar to those observed with penicillin were identified in ultrastructural analyses of C. trachomatis-infected mouse oviduct (88) . A similar observation was made in cell culture studies of C. psittaci-infected cells treated with DEAE-dextran or cycloheximide (110) . Pyknotic forms develop within aberrant RBs when the cells are treated with these two very different reagents.
Because chlamydiae are deficient in peptidoglycan (6, 31) , the mechanism of chlamydial growth inhibition by penicillin is unknown (76) . In C. trachomatis LGV-infected cultures, penicillin has no effect on the synthesis of MOMP; however, the synthesis of the cysteine-rich 60-kDa envelope protein, an integral component of structural integrity, is completely inhibited (21) . Ampicillin also blocks the conversion of RBs to EBs (98) . The effect of ampicillin on chlamydia-specific protein synthesis reveals that arrest of chlamydial development is accompanied by a marked inhibition in the expression of both VOL. 58, 1994 on November 2, 2017 by guest http://mmbr.asm.org/ Downloaded from 60-kDa and 12-kDa cysteine-rich proteins, while the production of MOMP is only minimally affected (98) . D-Cycloserine, also an inhibitor of peptidoglycan synthesis, has a growth-inhibiting effect on chlamydiae. In C. psiffaci MoPn-infected cells treated with this antibiotic 16 h after infection, the chlamydiae appear as abnormally large, swollen forms similar to those observed after penicillin treatment (78) . Growth inhibition of C. psittaci by D-cycloserine can be competitively reversed by its structural analog, D-alanine.
Chloramphenicol and chlortetracycline have also been shown to interrupt the intracellular development of chlamydiae (59, 119) . The effect of these inhibitors of prokaryotic protein synthesis is dependent on the stage during infection at which the chlamydia-infected cells are exposed to these antibiotics. Addition of these inhibitors early in infection prevents primary differentiation of EBs to RBs, whereas exposure later in infection interrupts RB division and secondary differentiation. A nearly identical situation occurs when the effect of erythromycin on chlamydial development is analyzed (23) . This macrolide antibiotic not only inhibits RB-to-EB differentiation but also induces notably smaller inclusions containing RBs of approximately twice the diameter of typical RBs. Erythromycin binds to the 50S subunit of the ribosome and may reduce RB ribosomal activity and subsequent protein synthesis. Decreased protein synthesis may result in a deficiency in membrane constituents or regulatory proteins required for differentiation.
Antibiotics that inhibit nucleic acid synthesis also have been shown to inhibit chlamydial development. 5-Fluorouracil affects late stages of the C. trachomatis LGV growth cycle (3) . Cells treated with 5-fluorouracil for 24 h appear similar to untreated cultures. However, by 48 h, smaller inclusions containing only a few noninfectious larger particles are present. When C. psittaci-infected fibroblasts are cultured in the presence of nalidixic acid, an inhibitor of DNA gyrase, binary fission of RBs and subsequent reorganization to EBs are inhibited (119) . Hydroxyurea, another inhibitor of DNA synthesis, also interrupts the developmental cycle of C. trachomatis by reversibly inhibiting the transformation of RBs to infectious EBs (94) . As observed with penicillin and ampicillin, this interruption in RB-to-EB differentiation is accompanied by the inhibition of the synthesis of cysteine-rich proteins (98) . Given the disparity in the molecular targets of these drugs, the reduced synthesis of cysteine-rich proteins may be secondary to alterations in regulatory signals which trigger RB-to-EB differentiation.
Sulfonamides also have been demonstrated to alter chlamydial morphology and development in cell culture (35, 36, 93) . Most C. trachomatis strains are susceptible to the antagonists of bacterial dihydrofolate reductase, whereas most C. psittaci strains are resistant (50, 60, 100) . Treatment of C. trachomatis-infected McCoy cells with trimethoprim or sulfomethazole at levels slightly below the MIC inhibit RB-to-EB differentiation characterized by the presence of gross changes in RB formation (35, 36) . By 48 h postinfection, inclusions contain irregular RBs, with ruffled membranes, mini-RB-like forms, and numerous ghost particles (36) . Culturing C. trachomatis-infected cells with increasing concentrations of both trimethoprim and sulfomethazole results in inclusions that are progressively smaller, pyknotic, and less abundant (35) . When cells containing these abnormal inclusions are transferred to drug-free medium, the morphology of subsequent inclusions is normal.
Persistent infection of McCoy cells with C. psittaci can be achieved by the addition of aminopterin within 20 h of infection (90) . Aminopterin inhibits dihydrofolate reductase, preventing conversion of dihydrofolic acid to tetrahydrofolic acid. Cultures lacking visible inclusions and infectivity can be maintained for 4 weeks, with chlamydial replication resuming upon addition of folinic acid.
A vast number of antibiotics inhibit chlamydial differentiation. The effects of different antibiotics seem to be dependent on the level present and the stage during the' developmental cycle in which infected cells are exposed to these substances. When comparing the alteration of chlamydial growth by these antibiotics in tissue culture, the primary molecular target for each is vastly different. This suggests that there is not a single mechanism by which differentiation is inhibited and persistence is generated.
Immunologically Induced Persistence
Abnormal or persistent chlamydiae have been recognized under a variety of artificial cell culture systems, but only recently have reasonable physiological mediators of persistence been identified and the biochemical and antigenic features of persistent chlamydiae characterized. Most of the work in this area has focused on immune'system-regulated cytokines that do not directly affect chlamydiae but, rather, cause alterations in the host cell, interfering with normal intracellular chlamydial growth. The most extensively studied of these cytokines is the T-cell product gamma interferon (IFN--y).
Chlamydiae were among the first nonviral pathogens reported to induce IFNs and were shown to exhibit growth inhibition in their presence (68) . Inhibition of intracellular chla,mydial growth by IFN in cell culture systems was reported by several groups (26, 38, 57, 95) . At the same time that these studies were being done, independent work focused on immune system-induced lymphokines and their inhibiting effects on intracellular chlamydial growth in macrophages (14, 15) . The active component in supematant fluids from stimulated T cells was identified as IFN--y (16, 97), which activated not only mononuclear phagocytes (97) but also fibroblasts (16) and epithelial cells. (17) to restrict intracellular chlamydial replication. IFN-y is a macrophage-activating factor which induces microbicidal products of oxygen metabolistn. However, oxygen-dependent mechanisms do not contribute to the restriction of chlamydial growth' (96, 106) . Rather, IFN-y was found to inhibit C. psittaci growth in a human,epithelial cell line by inducing indoleamine 2,3-dioxygenase, a nonconstitutive enzyme that catalyzes the degradation of tryptophan (17) . This mechanism has previously been implicated in activating host cells to restrict the obligate intracellular protozoan Tocoplasma gondii (87) . Depletion of exogenous tryptophan correlates with growth inhibition of both C psittaci and' C. trachomatis in a wide spectrum of human host cells including primary conjunctival epithelial cells (92) , the actual host cell that is infected during chlamydial ocular disease.
While high levels of IFN-y completely restrict chlamydial growth, low levels induce the development of morphologically aberrant intracellular forms (106) . These studies suggested that IFN-y treatment of host cells might lead to maintenance of chronic chlamydial infection. More recent studies have characterized the ultrastructural features associated with IFN--mediated persistent C. trachomatis infection (10) .' IFN-ly treatment of C. trachomatis serovar A-infected cells results in the development of enlarged, atypical, noninfectious forms distinct from both EBs and RBs (10) and morphologically similar to those induced by penicillin treatment (59, 67) (Fig.  3) . These persistent organisms not only exhibit a highly unusual intracellular morphology but also display differential expression of key chlamydial antigens (10, 11) (113, 129) . In addition, these forms exhibit a reduction in the levels of other structural constituents of chlamydiae, including the 60-kDa envelope protein and lipopolysaccharide (10) .
The term "persistence" implies a prolonged association between chlamydiae and their host cells. IFN--y-mediated persistent infection can be maintained for several weeks in cell culture, with reactivation of viable infectious organisms following the removal of IFN-,y at any time during the experimental time course (11) . It was not known if recovery of infectivity was a result of renewed growth and differentiation of typical RBs contained within the population of persistent chlamydiae or whether the persistent organisms themselves could reorganize in some fashion to produce infectious EBs. If the former hypothesis is true, it would imply that the persistent state is a dead-end pathway and not a true alternative mode of chlamydial development. In contrast, if the latter hypothesis is true, persistent organisms would retain the ability to undergo reactivation to infectious forms. Studies were done to distinguish between these two hypotheses (11) . The development of infectious chlamydiae from aberrant organisms is characterized by internal reorganization within the enlarged forms, extensive budding processes, and miniature-RB formation (Fig. 4) , with subsequent emergence of morphologically typical EBs (11) . Multiple nucleoid-like masses within the aberrant forms following IFN--y removal are similar to intrachlamydial structures observed under nutrient-deficient conditions (25). These observations suggest that endopolygeny, in which several progeny are generated from a single aberrant chlamydial form, may occur.
Studies that demonstrate a role for IFN-y in activating host cells to restrict subsequent chlamydial growth require relatively large amounts of IFN--y, with host cells treated for at least 24 h prior to infection to achieve optimal growth inhibition (17, 105, 106) . Persistence of C. trachomatis occurs when very low levels of IFN-,y are added to culture systems following infection of the host cells (10, 11) . The differences in experimental design required to induce persistence as opposed to growth inhibition are probably more representative of conditions that exist during an actual chlamydial disease, that is, the presence of infected cells prior to the release of IFN--y by activated T cells and a relatively modest level of IFN-y at the site of infection.
Morphological features associated with IFN--y-mediated persistence have similarities to those of abnormal growth induced by penicillin. It is striking that such completely different mediators lead to abnormal organisms that share many of the same characteristics, further legitimizing these aberrant forms. The fact that an immune system-regulated cytokine can cause these alterations provides a reasonable physiological mechanism for their induction in vivo. The antigenic changes that accompany reactivation of penicillin-treated organisms have never been characterized, but it would not be surprising if similar changes to those reported for IFN-y-induced persistence were observed.
Not only does intracellular growth of chlamydiae in the presence of penicillin induce persistence, but also infected cells release chlamydial hsp60, which upon purification mediates an ocular delayed-hypersensitivity response in immune guinea pigs (72) . If secretion of hsp6O also occurs in response to IFN--y, this would have further implications in the stimulation of immunopathologic changes following infection and the development of immune system-mediated chlamydial persistence. Evidence that persistent chlamydial growth is associated with an increase in the expression of chlamydial hsp60 (11) suggests that persistent growth of chlamydiae ultimately may be a stress-related response. As anticipated, heat shock of Chlamydia-infected cells results in enlarged aberrant forms typical of penicillin and IFN--y treatment (53 Interruptions in the typical growth cycle of chlamydiae have been recognized for decades and are associated with abnormal developmental forms. The vast number of factors associated with altered growth suggests that the "normal" chlamydial growth cycle, as defined in cell culture, may not be the only process of chlamydial development, especially in the complex environment of a natural infection.
Summary of Alterations Associated with In Vitro Persistence
Several studies have characterized inhibition of chlamydial growth by microscopy and found it to be associated with an alteration in the typical chlamydial developmental cycle such that unusual forms with properties distinct from both EBs and RBs emerge. The distinct features associated with altered chlamydial development are shown in Fig. 4 . These unique alterations have been identified by using antibiotics, nutrientdeficient conditions, and immune system-regulated factors (3, 10, 25, 49, 59, 67, 78, 107, 115) . Further characterization of this alteration to aberrant chlamydial growth reveals that several factors inhibit the generation of infectious progeny, although the abnormal organisms remain viable (10, 30) . In addition, penicillin, ampicillin, hydroxyurea, cAMP, IFN-y, and cysteine depletion have all been implicated in impairment of the synthesis of one or more of the key structural components of chlamydiae (1, 10, 21, 55, 98) .
Normally, chlamydiae undergo an orderly alternation between two developmentally regulated forms, the infectious EB and the metabolically active RB. Late in the developmental cycle, redifferentiation of the RBs to the infectious EBs is accompanied by the synthesis and incorporation of MOMP and other OMPs into outer membrane complexes (42) . Thus, division and differentiation appear to be dependent on the availability and appropriate cross-linking of these OMPs. Interruptions in the synthesis of outer membrane constituents may result in continued chlamydial growth without proper division and differentiation, accounting for inclusions containing fewer organisms that are morphologically enlarged. Alternately, a reduction in outer membrane integrity may allow for increased osmotic influx, accounting for the swollen chlamydial structures. In contrast, reduced levels of OMPs may be secondary to the suppression of signaling pathways that prevent binary fission of RBs and redifferentiation to EBs. The resulting decrease in the surface-to-volume ratio of enlarged atypical structures, compared with normal chlamydial RB and EB forms, would account for the decrease in structural outer membrane constituents.
PERSISTENCE OF CHLAMYDIAE IN VIVO
Chlamydial persistence has been established in a variety of cell culture systems; however, conclusive documentation of persistent chlamydiae in natural infections remains to be demonstrated. Indirect evidence indicates that such conditions occur and may contribute to the immunopathogenesis associated with both ocular and genital chlamydial diseases.
Evidence for Persistence in Ocular Infections
Although a clear correlation between trachoma and infection with C. trachomatis has been established, chlamydiae cannot be identified by tissue culture or immunocytological methods in over 20% of cases, even in the presence of severe abnormalities (116, 117) . A variable range of clinical manifestations has been reported for the course of this disease. A subset of individuals with active chlamydial infection displaying moderate to severe trachoma had no detectable viable organisms (102) . Other studies have identified individuals with severe scarring disease who were positive immunocytologically but were culture negative (64) . The converse situation has also been described in cases involving ocular infections in which chlamydial inclusions were found in the absence of clinical signs of disease (37) .
The diverse clinical manifestations of chlamydial ocular infection correlate to different stages of the disease process. In VOL. 58, 1994 on November 2, 2017 by guest http://mmbr.asm.org/ Downloaded from areas where trachoma is endemic, early stages of the disease are characterized by mild clinical symptoms, generally associated with younger individuals experiencing active infection as detected by the presence of cultivatable chlamydiae (32) . Older individuals who have been exposed to repeated infections display complications of ocular scarring and fibrosis, corneal trauma, and blindness, even though C. trachomatis is rarely isolated from the diseased tissue (32) . Progressive scarring disease with clinically inapparent, nonproductive (culture-negative) infection indicates that these individuals may harbor a cryptic form of chlamydiae in the infected tissue. The presence of such quiescent chlamydial forms is further suggested by studies of individuals who left areas where trachoma was endemic and had not experienced active disease since childhood but developed acute trachoma several decades later (101) . Therefore, viable chlamydiae may be present in a latent, nonreplicating form, inconspicuously contributing to the progression of disease toward blinding trachoma.
Strong evidence for the continued presence of C. trachomatis in a culture-negative state comes from studies of trachoma patients and a primate model for ocular disease in which the presence of unamplified chlamydial rRNA in conjunctival swabs was demonstrated long after antigen detection was negative (22, 46, 48) . Because RNA molecules are very labile, identification of chlamydial RNA indicates that chlamydiae may persist in diseased tissue in a culture-negative but viable form. Chlamydial rRNA also has been detected in the synovium of patients with Reiter's disease, in the absence of cultivatable chlamydial organisms, suggesting that intact, culture-negative organisms persist in the joints (91) .
These studies indicate that viable chlamydiae may be present at the site of infection and induce an inflammatory response beyond the time when standard techniques can detect the organism. However, confirmation of the contribution of chlamydial persistence to the disease process awaits identification of latent but viable chlamydiae in natural infection.
Evidence for Persistence in Genital Infections
The identification of C. trachomatis as an etiological agent of infertility in women is well recognized. Infection of the cervix by C. trachomatis may be chronic, persisting unrecognized for months to years unless a symptomatic infection of a male partner occurs. Approximately 70% of women with C. trachomatis cervicitis have only mild symptoms or remain asymptomatic (20) . Unrecognized infection can progress, ascending to the salpinges and fallopian tubes and resulting in pelvic inflammatory disease. A large proportion of C. trachomatis infections of the fallopian tubes are also asymptomatic or subclinical, influencing the potential for the development of the adverse sequelae of infertility and ectopic pregnancy. Silent infections are the most common cause of tubal infertility, with only one-third of infertile women having a history of pelvic inflammatory disease (103, 118) . Several studies indicate a strong association between serological evidence of a previous C. trachomatis infection and obstructive infertility (13, 44, 45, 51, 70, 84, 108) ; however, recovery of viable chlamydiae from tubal biopsy specimens is rare (13, 54, 70, 118) . Few studies have demonstrated isolation of C. trachomatis from damaged tissue of the upper genital tract (44, 45) ; in one study, multiple passages in culture were required for isolation of infectious organisms (108) . Whether chlamydiae persist subclinically in the upper genital tract of women, with resulting infertility, is unclear and remains a matter of debate.
Although chlamydiae are difficult to culture, especially when the disease process has become chronic, the presence of chlamydial antigen and nucleic acids is indicative of persisting organisms. A number of studies have identified C. trachomatis antigen in endometrial and tubal specimens of culture-negative infertile women (18, 58, 118) . Chlamydia-specific DNA has been identified in endocervical cells and fallopian tube tissue of women with tubal occlusion (18, 109) . Only a fraction of samples positive for chlamydia-specific DNA were also positive by immunocytological techniques for the chlamydial MOMP, an antigen detected in diagnostic tests for chlamydiae (18, 109) .
There are several possible explanations for why the presence of chlamydial antigens, resulting in immunologic stimulation and disease, may continue in the absence of cultivatable organisms. Residual chlamydial antigens and DNA may remain from a previous, completely eradicated infection. However, because of the prolonged course of these diseases, it seems improbable that long-term chronic inflammation and disease could be attributed to nonreplicating chlamydial antigen residing in the diseased tissue. The inability to verify the presence of C. trachomatis by routine culture may indicate that such procedures are not sensitive enough to detect low but immunologically significant levels of chlamydiae. In addition, the presence of neutralizing antibody or host-elaborated metabolic inhibitors may interfere with detection by culture. Alternatively, affected individuals may harbor a persistent form of chlamydiae that possesses the characteristics of noncultivatable RBs but retains viability and the capacity to stimulate immunopathologic changes. However, evidence of chlamydial antigen and nucleic acids in the absence of cultivatable organisms only suggests the possibility of persisting chlamydiae (18, 22, 118) . These studies have not examined patients over time; therefore, there is no direct evidence for a long-term culturenegative state in patients with C. trachomatis genital infections.
Mediators of Reactivation in Natural Infection
Experimentally induced persistence indicates that a number of factors can arrest intracellular chlamydial development from which infectious organisms cannot be isolated. Removal of these factors leads to a resumption of active growth of chlamydiae and development of infectious progeny. Reactivation of apparently resolved chlamydial infection in vivo occurs under conditions of immunosuppression, implicating the immune response in maintenance of persistent infection (120, 127) . A number of physiologic environmental stimuli may reactivate such quiescent infections to generate a prolific growth state with the production of infectious, immunologically significant forms. The epidemiological relationship between Neisseria gonorrhoeae and C. trachomatis suggests that concurrent infection may play a role in reactivation of inapparent chlamydial infections (8, 81) . Chlamydiae are isolated in significantly greater numbers from women with gonorrheal infection than from those without (83) . In addition, women exposed to partners with gonorrhea are more likely to yield chlamydiae if they become infected with N. gonorrhoeae than if they do not (83) . In addition to gonococcal infection, trauma to the genital tract is thought to stimulate mucosal turnover, potentially triggering the conversion of persistent chlamydiae to an active growth phase (19) . With the constant fluctuation in environmental conditions, a number of undefined factors (immune factors, nutrients, and hormones in genital infections) may stimulate a productive infection.
CORRELATIONS BETWEEN CELL CULTURE MODEL SYSTEMS AND EVENTS OCCURRING IN NATURAL INFECTIONS
In cell culture, 48 to 72 h following infection, lysis of the host cell can result in the release of hundreds of chlamydiae, each capable of eliciting a new round of infection. It is presumed that the chlamydial developmental cycle progresses in a similar manner during natural infection. Such a sequence of events would result in the rapid progression of the infectious process. However, chlamydial infections tend to exhibit a prolonged course, being insidious and asymptomatic. Although there is no direct evidence for altered chlamydial development in vivo, it is possible that chlamydial growth in natural infections is more complex, with interruptions in chlamydial differentiation and production of infectious progeny similar to events defined in cell culture models for persistence.
Chlamydiae infect mucosal epithelial cells; however, it is improbable that this is the site of persistent infection, because of the natural turnover of these target cells. Natural turnover and lysis of sloughed cells would result in release of chlamydial antigens and stimulation of the immune response but also in loss of persistently infected cells. However, recent evidence indicates that C. trachomatis may reside in the subepithelial tissue (18) , thus allowing chlamydiae to persist for extended periods. It is likely that persistence of chlamydiae in natural infections encompasses a number of events to allow for maintenance of a long-term association. This includes alternations between the development of metabolically inactive persisting forms and periods of low-level multiplication. In addition, a balance established with the host cells may allow for continued multiplication of these cells, which in turn may result in cell-to-cell transfer of persistent chlamydiae at host cell division without lysis and immune stimulation.
Persistence of different biotypes of C. psittaci was thought to reflect differences in the capacity to enter a persistent relationship with their hosts during a natural infection (86) . This idea is significant in that it suggests distinctions between clinical syndromes that are both strain and host cell related. If C.
trachomatis has similar distinctions, it is possible that ocular and genital strains will exhibit different behaviors. Analysis of the amino acid requirements for C. trachomatis growth reveals that all strains tested require leucine, phenylalanine, and valine for normal growth (2) . Genital serovars also require histidine and glutamine, while ocular serovars require all of these plus tryptophan (2) . This requirement for tryptophan only by ocular strains is significant to the studies of IFN--y-mediated induction of the persistence of C. trachomatis serovar A (10). The effects of IFN--y on restricting the replication of genital C. trachomatis serovars may be governed by different IFN--y-induced activities, or the effects of indoleamine 2,3-dioxygenase may be more complex than merely starvation of tryptophan. Stimulation by hormones, cytokines, or other factors may alter the growth of genital serovars, providing distinctions between the behavior of chlamydiae in different anatomical locations and disease syndromes.
Diagnosis of active chlamydial infection often entails sampling genital or conjunctival specimens for cultivatable chlamydiae. However, chlamydiae are often difficult to culture from diseased tissue, even though there may be evidence of progressive scarring (18, 109, 118, 121) . This situation correlates with in vitro studies which show that chlamydiae can persist in host cells in abnormal forms that are noninfectious but retain viability (10) . Immunofluorescent-antibody tests are used for direct examination of clinical specimens for chlamydial inclusions, typically utilizing antibodies to chlamydial MOMP and lipopolysaccharide. A number of factors shown to induce a persistent state in vitro are associated with a reduction in the levels of chlamydial MOMP (10, 55, 98) , and lipopolysaccharide (10), indicating that if such an infection occurred in vivo, standard diagnostic immunofluorescent-antibody assays might lack the appropriate specificity to identify persistent forms of the organism. These studies may be helpful in establishing a rational basis for the development of alternative methods for demonstrating the presence of chlamydiae in cases of disease when culture and direct antigen detection methods prove to be negative. Cell culture model systems for persistence indicate that detection of infection may require the identification of enlarged, aberrant chlamydial forms within diseased tissue or diagnostic immunolabeling with antibodies to chlamydial antigens that continue to be synthesized in the persistent state, such as hsp6O (11) .
Current available treatment regimens for C. trachomatis infections entail a 7-to 10-day course of tetracycline, erythromycin, or doxycycline (111) . These multidose therapies have considerable potential for patient noncompliance, especially by individuals who are asymptomatic or display minimal symptoms. Inadequate doses or duration of therapy may result in incomplete clearance of the organism, with temporary inhibition of chlamydial growth, allowing for subsequent relapse. This prospect is analogous to cell culture studies assessing antichlamydial activity of different antibiotics. Eradication, as opposed to transient inhibition or induction of persistent chlamydial growth by antimicrobial agents, is contingent upon the duration of treatment, the dose, and the stage of the growth cycle during which chlamydiae are exposed to these agents.
Current clinical studies indicate that the antibiotic azithromycin is a promising single-dose therapy for C. trachomatis infections, potentially eliminating the problem of noncompliance (111) . However, the prolonged course of C. trachomatis diseases and their tendency to progress asymptomatically reemphasize the potential of incomplete eradication, despite presumably appropriate antimicrobial therapy. A 7-day regimen of ciprofloxacin for treatment of Chlamydia-positive nongonococcal urethritis rendered patients culture negative after 2 to 3 days; however, C. trachomatis was reisolated within 4 weeks of the initial treatment (47) . The recurrent strain in all cases had an identical serotype to the original infecting strain.
In addition, there was a strong correlation between recurrences and the number of chlamydial infectious units present prior to treatment, suggesting that recurrent infection was a result of persisting organisms and not of reinfection. In contrast, a 7-day regimen of doxycycline effectively eradicated chlamydial lower genital tract infections, with individuals remaining negative by both PCR and culture for 5 months following treatment (125) . The latter studies indicate that persistence of C. trachomatis may not be a factor in uncomplicated urogenital infections following appropriate antimicrobial therapy. It has been suggested that early treatment of chlamydial infections is successful whereas antibiotic therapy during the chronic phase generally has little effect (82) . There are several reasons to suspect that persistent chlamydiae may not respond to antibiotics as well as normally growing chlamydiae would. First, persistent chlamydiae may contain reduced levels of MOMP (10) . MOMP not only acts as an antigen likely to stimulate protective immunity but also functions as a porin (9) . In the absence of MOMP, large hydrophilic molecules, including many antibiotics, may not be transported into the chlamydial cell. However, currently there is no evidence that MOMP functions in the transport of drugs. Second, since persistence VOL. 58, 1994 on November 2, 2017 by guest http://mmbr.asm.org/ Downloaded from appears to be a manifestation of a stress-related response, and since stress responses are known to induce phenotypic resistance to antibiotics in other bacteria (128) , it might be expected that persistent chlamydiae would be less sensitive to antibiotics than normally growing organisms are. Finally, when clinical isolates of chlamydiae resistant to tetracycline were cultured, organisms growing in the presence of high levels of tetracycline exhibited a morphology strikingly similar to that of persistent chlamydiae as defined by the IFN--y model (50) . However, it is unclear if tetracycline is failing to eradicate a persistent infection or if the antimicrobial itself induces altered chlamydial growth (50, 52) . If will provide additional clues to the interaction between chlamydiae and their host and induction of chlamydial persistence in a natural infection. Further studies will be helpful in establishing effective antibiotic usage strategies, as well as a rational basis for the development of alternate methods for the detection of persistent chlamydiae, when culture and direct antigen detection methods prove to be negative. However, confirmation of the contribution of chlamydial persistence to the disease process awaits the identification of latent but viable organisms in natural infection. The identification of persisting chlamydial organisms will impact our knowledge of the pathogenesis of chlamydial disease and provide a more complete (and possibly more accurate) understanding of the chlamydia-host cell interaction in natural infections.
